The Insigneo Institute for in silico Medicine has hosted the annual Showcase event.

A record number of 218 visitors to this year’s Insigneo Showcase heard how in silico medicine – computer simulations of the human body and its disease processes – can help improve diagnosis and prognosis for conditions like Parkinson’s and Diabetes. Although ultimately destined for the clinic, the technology looks likely to move quickly into use within clinical trials, as it can enable more effective monitoring of the impact of new drugs and treatments.

The project MISSION-T2D has participated to the event with a stand presentation and live demo of the MISSION-T2D feature embedded in the VitaDock+ mobile app by partner Medisana.

INSIGNEO                                                                          05/05/16